Adverse events182

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 182

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk	Events
other	Anaemia	Blood and lymphatic system disorders	Polatuzumab Vedotin Plus Bendamustine and Rituximab	16	27	28
other	Anaemia	Blood and lymphatic system disorders	Placebo Plus Bendamustine and Rituximab	5	14	7
other	Leukocytosis	Blood and lymphatic system disorders	Polatuzumab Vedotin Plus Bendamustine and Rituximab	1	27	1
other	Leukocytosis	Blood and lymphatic system disorders	Placebo Plus Bendamustine and Rituximab	1	14	1
other	Leukopenia	Blood and lymphatic system disorders	Polatuzumab Vedotin Plus Bendamustine and Rituximab	3	27	5
other	Leukopenia	Blood and lymphatic system disorders	Placebo Plus Bendamustine and Rituximab	0	14	0
other	Myelosuppression	Blood and lymphatic system disorders	Polatuzumab Vedotin Plus Bendamustine and Rituximab	0	27	0
other	Myelosuppression	Blood and lymphatic system disorders	Placebo Plus Bendamustine and Rituximab	1	14	1
other	Neutropenia	Blood and lymphatic system disorders	Polatuzumab Vedotin Plus Bendamustine and Rituximab	4	27	4
other	Neutropenia	Blood and lymphatic system disorders	Placebo Plus Bendamustine and Rituximab	3	14	3
other	Thrombocytopenia	Blood and lymphatic system disorders	Polatuzumab Vedotin Plus Bendamustine and Rituximab	3	27	3
other	Thrombocytopenia	Blood and lymphatic system disorders	Placebo Plus Bendamustine and Rituximab	2	14	2
other	Bradycardia	Cardiac disorders	Polatuzumab Vedotin Plus Bendamustine and Rituximab	0	27	0
other	Bradycardia	Cardiac disorders	Placebo Plus Bendamustine and Rituximab	1	14	1
other	Palpitations	Cardiac disorders	Polatuzumab Vedotin Plus Bendamustine and Rituximab	1	27	2
other	Palpitations	Cardiac disorders	Placebo Plus Bendamustine and Rituximab	1	14	1
other	Sinus tachycardia	Cardiac disorders	Polatuzumab Vedotin Plus Bendamustine and Rituximab	3	27	3
other	Sinus tachycardia	Cardiac disorders	Placebo Plus Bendamustine and Rituximab	1	14	1
other	Deafness	Ear and labyrinth disorders	Polatuzumab Vedotin Plus Bendamustine and Rituximab	0	27	0
other	Deafness	Ear and labyrinth disorders	Placebo Plus Bendamustine and Rituximab	1	14	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04236141/events

API reference For AI assistants

Adverse events182

Sources 3

Read this list from software.